GLP-1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation
Substance use disorders (SUD), including alcohol use disorder (AUD) and opioid use disorder (OUD), are a growing public health crisis, contributing significantly to morbidity, mortality, and health care resource utilization [1]. In 2020, an estimated 40.3 million individuals aged 12 or older in the United States (US) had SUD […